You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
|
|---|---|
| Published in |
npj Breast Cancer, October 2023
|
| DOI | 10.1038/s41523-023-00584-5 |
| Pubmed ID | |
| Authors |
Naoki Niikura, Takashi Yamanaka, Hironori Nomura, Kazuhiro Shiraishi, Hiroki Kusama, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Shosuke Kita, Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, Shuji Sakai, Yoko Kiga, Tadahiro Izutani, Kazuhito Shiosakai, Junji Tsurutani |
X Demographics
The data shown below were collected from the profiles of 126 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 38 | 30% |
| Brazil | 5 | 4% |
| Italy | 5 | 4% |
| Japan | 3 | 2% |
| Canada | 3 | 2% |
| Belgium | 3 | 2% |
| Australia | 2 | 2% |
| Mexico | 2 | 2% |
| Turkey | 2 | 2% |
| Other | 16 | 13% |
| Unknown | 47 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 64 | 51% |
| Practitioners (doctors, other healthcare professionals) | 40 | 32% |
| Scientists | 19 | 15% |
| Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 13 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 2 | 15% |
| Researcher | 1 | 8% |
| Student > Postgraduate | 1 | 8% |
| Student > Doctoral Student | 1 | 8% |
| Unknown | 8 | 62% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 15% |
| Unspecified | 1 | 8% |
| Immunology and Microbiology | 1 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
| Unknown | 8 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 80. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2023.
All research outputs
#549,807
of 25,918,061 outputs
Outputs from npj Breast Cancer
#22
of 610 outputs
Outputs of similar age
#9,916
of 362,620 outputs
Outputs of similar age from npj Breast Cancer
#1
of 18 outputs
Altmetric has tracked 25,918,061 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 610 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,620 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.